PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28419192-0	2017	Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer"s disease: a Phase II multicenter randomised controlled trial.	octahydroaminoacridine	62-84	acetylcholinesterase (Cartwright blood group)	Homo sapiens	31-51	
28419192-2	2017	Octohydroaminoacridine, a new AChE inhibitor, is a potential treatment for AD.	octahydroaminoacridine	0-22	acetylcholinesterase (Cartwright blood group)	Homo sapiens	30-34